Medincell (CHIX:MEDCLP) 3-Year Revenue Growth Rate : 40.60% (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Medincell 3-Year Revenue Growth Rate?

Medincell's Revenue per Share for the six months ended in Sep. 2023 was €0.25.

During the past 12 months, Medincell's average Revenue per Share Growth Rate was 19.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 40.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of Medincell was 40.60% per year. The lowest was -47.10% per year. And the median was -6.00% per year.

Competitive Comparison of Medincell's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Medincell's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medincell's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medincell's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Medincell's 3-Year Revenue Growth Rate falls into.

Medincell 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Medincell (CHIX:MEDCLp) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Medincell 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Medincell's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medincell (CHIX:MEDCLP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (CHIX:MEDCLp) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

MEDCL:France MEB:Germany

Address

3 rue des Freres Lumiere, Jacou, FRA, 34830

Website

https://www.medincell.com

Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Medincell (CHIX:MEDCLP) Headlines

No Headlines